How one Boston startup rode the diabetes investment wave to raise $126M

Within 24 months of launching in 2015, diabetes device firm Beta Bionics grabbed the attention of industry giants like Eli Lilly and Novo Nordisk. But when Boston University professor Ed Damiano set out to raise a new tranche of funding for the startup last year, his hopes were low.